| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |